EUVIMEDEUVIMED entdecken
Vergleichsstudie

Long‐Term Outcome of Radiofrequency Versus Pulsed‐Field Ablation in Atrial Fibrillation Patients Aged More Than 60 Years Undergoing Their First Catheter Ablation

Pamela Horton Embrey, Sanghamitra Mohanty iD, Prem Geeta Torlapati, Vincenzo Mirco La Fazia, Carola Gianni, Yaseen Eleyan, Bryan MacDonald, Angel Mayedo, Amin Al-Ahmad iD, John David Burkhardt, John Allison, Weeranun Bode und 3 weitere

Journal of Cardiovascular Electrophysiology · 2025

DOI: 10.1111/jce.70101 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Pamela Horton Embrey und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We evaluated the impact of pulsed‐field (PFA) vs. radiofrequency ablation (RFA) on long‐term ablation outcome in AF patients and whether the benefit was extended to all age groups, in a real‐world population.

Methods

Consecutive AF patients undergoing their first ablation procedure were classified based on their age at baseline; group 1: > 60 years and group 2: ≤ 60 years. Each group were then subclassified based on the energy modality used; group 1A or 2A: received RFA, and group 1B or 2B: underwent PFA. All patients received isolation of PVs and left atrial posterior wall.

Results

A total of 1386 patients were included in group 1 (Gr 1A: 954; Gr 1B: 432) and 414 subjects in group 2 (Gr 2A: 284; Gr 2B: 130). Patients in group 1 were sicker with more comorbidities. At the end of 1‐year follow‐up, significantly higher recurrence rate was reported in group 1 patients receiving RFA compared to PFA (249 (26.1%) vs. 45 (10.4%), p < 0.001), whereas the recurrence rate was comparable between the two subgroups in group 2 (RFA: 69 (24.3%) vs. PFA: 22 (17%), p = 0.095). Mean time to recurrence was significantly longer in the Gr. 2B (PFA) population compared to RFA (7.21 ± 1.87 vs. 7.75 ± 2.03 months, p = 0.008) and comparable in Gr. 1 (RFA: 7.98 ± 1.29 vs. PFA: 8.12 ± 1.80 months, p = 0.531). After controlling for the variables in the multivariate model, PFA was associated with lower risk (OR = 0.378, 95% CI 0.265, 0.539; p ‐value < 0.001) and Persistent AF with higher risk of recurrence (OR = 1.745, 95% CI 1.562, 1.986; p ‐value = 0.040).

Conclusion

PFA was associated with a significantly lower recurrence rate in patients > 60 years of age with more comorbidities compared to RFA. However, in patients aged ≤ 60 years, no difference in RFA vs. PFA in terms of recurrence rate was observed. Mean time to recurrence was comparable between PFA and RFA subgroups in the group 1 population, whereas it was significantly higher in group 2 PFA vs. RFA subgroup.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationPulmonary VeinsHumansMaleFemaleMiddle AgedTreatment OutcomeTime FactorsRecurrenceAgedRisk FactorsAge FactorsAction PotentialsRetrospective StudiesHeart RateRisk Assessment

Stichwörter der Autor:innen

agepulsed‐field ablationradiofrequency ablationrecurrence

Autor:innen und Institutionen

  • Division of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
  • Metro Health Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Department of Biomedicine and Prevention, Division of Cardiology, University of Tor Vergata, Rome, Italy.
  • Interventional Electrophysiology, Scripps Clinic, San Diego, California, USA.

ORCID-Profile: Sanghamitra Mohanty, Amin Al-Ahmad, Andrea Natale

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Embrey, P. H., Mohanty, S., Torlapati, P. G., La Fazia, V. M., Gianni, C., Eleyan, Y., MacDonald, B., Mayedo, A., Al-Ahmad, A., Burkhardt, J. D., Allison, J., Bode, W., Gallinghouse, G. J., Horton, R., & Natale, A. (2025). Long‐Term Outcome of Radiofrequency Versus Pulsed‐Field Ablation in Atrial Fibrillation Patients Aged More Than 60 Years Undergoing Their First Catheter Ablation. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70101

Vancouver

Embrey PH, Mohanty S, Torlapati PG, La Fazia VM, Gianni C, Eleyan Y, et al. Long‐Term Outcome of Radiofrequency Versus Pulsed‐Field Ablation in Atrial Fibrillation Patients Aged More Than 60 Years Undergoing Their First Catheter Ablation. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.70101

BibTeX
@article{Embrey2025,
  author = {Embrey, Pamela Horton and Mohanty, Sanghamitra and Torlapati, Prem Geeta and La Fazia, Vincenzo Mirco and Gianni, Carola and Eleyan, Yaseen and MacDonald, Bryan and Mayedo, Angel and Al-Ahmad, Amin and Burkhardt, John David and Allison, John and Bode, Weeranun and Gallinghouse, G J and Horton, Rodney and Natale, Andrea},
  title = {Long‐Term Outcome of Radiofrequency Versus Pulsed‐Field Ablation in Atrial Fibrillation Patients Aged More Than 60 Years Undergoing Their First Catheter Ablation},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  doi = {10.1111/jce.70101}
}
Kostenlos starten →